Literature DB >> 20524113

Accumulation of gene-targeted Bacillus subtilis mutations that enhance fermentative inosine production.

Takayuki Asahara1, Yukiko Mori, Natalia P Zakataeva, Vitaliy A Livshits, Ken-ichi Yoshida, Kiyoshi Matsuno.   

Abstract

In order to test a possible approach to enhance fermentative inosine production by Bacillus subtilis, seven gene-targeted mutations were introduced in the laboratory standard strain168 in a stepwise fashion. The mutations were employed in order to prevent inosine 5'-monophosphate (IMP) from being consumed for AMP and GMP synthesis, to minimize inosine degradation, and to expand the intracellular IMP pool. First, the genes for adenylosuccinate synthase (purA) and IMP dehydrogenase (guaB) were inactivated. Second, two genes for purine nucleoside phosphorylase, punA and deoD, were inactivated. Third, to enhance purine nucleotide biosynthesis, the pur operon repressor PurR and the 5'-UTR of the operon, containing the guanine riboswitch, were disrupted. Finally, the -10 sequence of the pur promoter was optimized to elevate its transcription level. The resulting mutant was capable of producing 6 g/L inosine from 30 g/L glucose in culture broth without the detectable by-production of hypoxanthine. This indicates the validity of this approach for the breeding of the next generation of B. subtilis strains for industrial nucleoside production.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20524113     DOI: 10.1007/s00253-010-2646-8

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  12 in total

1.  The structure of a tetrahydrofolate-sensing riboswitch reveals two ligand binding sites in a single aptamer.

Authors:  Jeremiah J Trausch; Pablo Ceres; Francis E Reyes; Robert T Batey
Journal:  Structure       Date:  2011-09-08       Impact factor: 5.006

2.  Reconstruction of Purine Metabolism in Bacillus subtilis to Obtain the Strain Producer of AICAR: A New Drug with a Wide Range of Therapeutic Applications.

Authors:  K V Lobanov; L Errais Lopes; N V Korol'kova; B V Tyaglov; A V Glazunov; R S Shakulov; A S Mironov
Journal:  Acta Naturae       Date:  2011-04       Impact factor: 1.845

3.  Increased production of inosine and guanosine by means of metabolic engineering of the purine pathway in Ashbya gossypii.

Authors:  Rodrigo Ledesma-Amaro; Ruben M Buey; Jose Luis Revuelta
Journal:  Microb Cell Fact       Date:  2015-04-17       Impact factor: 5.328

4.  Mutagenetic study of a novel inosine monophosphate dehydrogenase from Bacillus amyloliquefaciens and its possible application in guanosine production.

Authors:  Jian Wang; Kuifu He; Qingyang Xu; Ning Chen
Journal:  Biotechnol Biotechnol Equip       Date:  2014-01-02       Impact factor: 1.632

5.  Deregulation of purine pathway in Bacillus subtilis and its use in riboflavin biosynthesis.

Authors:  Ting Shi; Yongcheng Wang; Zhiwen Wang; Guanglu Wang; Dingyu Liu; Jing Fu; Tao Chen; Xueming Zhao
Journal:  Microb Cell Fact       Date:  2014-07-15       Impact factor: 5.328

6.  Metabolic and genetic factors affecting the productivity of pyrimidine nucleoside in Bacillus subtilis.

Authors:  Hui Zhu; Shao-Mei Yang; Zhao-Min Yuan; Rui Ban
Journal:  Microb Cell Fact       Date:  2015-04-15       Impact factor: 5.328

7.  Bacillus subtilis 5'-nucleotidases with various functions and substrate specificities.

Authors:  Ayako Terakawa; Ayane Natsume; Atsushi Okada; Shogo Nishihata; Junko Kuse; Kosei Tanaka; Shinji Takenaka; Shu Ishikawa; Ken-Ichi Yoshida
Journal:  BMC Microbiol       Date:  2016-10-26       Impact factor: 3.605

Review 8.  Engineered Microorganisms for the Production of Food Additives Approved by the European Union-A Systematic Analysis.

Authors:  Nicolai Kallscheuer
Journal:  Front Microbiol       Date:  2018-08-03       Impact factor: 5.640

Review 9.  Chasing bacterial chassis for metabolic engineering: a perspective review from classical to non-traditional microorganisms.

Authors:  Patricia Calero; Pablo I Nikel
Journal:  Microb Biotechnol       Date:  2018-06-21       Impact factor: 5.813

10.  Gut microbiota-derived inosine from dietary barley leaf supplementation attenuates colitis through PPARγ signaling activation.

Authors:  Daotong Li; Yu Feng; Meiling Tian; Junfu Ji; Xiaosong Hu; Fang Chen
Journal:  Microbiome       Date:  2021-04-05       Impact factor: 14.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.